Emergency Total ECLS vs Standard ACLS With ECMO Bailout for Survival in Refractory OHCA
ECLS-OHCA
Emergency Total Extracorporeal Life Support Versus Standard Advanced Cardiac Life Support With ECMO Bailout for Survival With Favorable Neurological Outcome in Refractory Out-of-Hospital Cardiac Arrest
1 other identifier
interventional
332
1 country
1
Brief Summary
The goal of the clinical trial is to learn if early extracorporeal life support ( ECLS ) will save more out-of-hospital cardiac arrest ( OHCA ) patients with good neurological outcome. It will also learn if emergency ECLS is safe in the OHCA rescue. Researchers aim to investigate if emergency total ECLS is better than standard advanced cardiac life support ( ACLS ) first, followed by bailout ECMO if required, for survival with favorable neurological outcome in OHCA patients. Participants meeting criteria of OHCA with witness, bystander CPR, shockable initial rhythm with repeated defibrillation, and transport time less than 30 min will be compared between total ECLS versus standard ACLS first with bailout ECMO protocols. All participants will receive emergency interventional coronary revascularization , intensive care unit therapy , cardiac ward care and up to 180 days of clinical follow up after survival .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2024
CompletedStudy Start
First participant enrolled
November 1, 2024
CompletedFirst Posted
Study publicly available on registry
November 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
May 18, 2025
September 1, 2024
3 years
September 15, 2024
May 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The rate of survival with favorable neurological outcome ( modified Rankin score less than 3 or cerebral performance category scale 1 or 2 ) at 30 days after discharge from hospital, in percentage
After survival discharge from hospital, clinical followup at out-patient clinic or by visual phone interview is conducted to assess medical health status as well as neurological status of the patients at 30 days after discharge from hospital. Survival with favorable neurological outcome ( i.e. modified Rankin score less than 3 or cerebral performance category scale 1 or 2 ) is to be measured as percentage of all randomized patients fulfilling inclusion criteria and without any exclusion criteria.
From randomization to 30 days after survival discharge from hospital
Secondary Outcomes (7)
Total duration of cardioplumonary resuscitation from on-site CPR by EMS till the stable ROSC or initiation of ECMO life support or the decease of the subject at emergency department up to 30 days after randomization, in minutes
From the start of on-site CPR by EMS till the return of stable ROSC or the initiation of ECMO life support or the decease of the subject at the emergency department up to 30 days after randomization, in minutes
The rate of survival with favorable neurological outcome ( modified Rankin score less than 3 or CPC scale 1 or 2 ) from the date of randomization to the date of discharge from hospital up to 180 days after randomization, in percentage
From the date of randomization to the date of discharge from hospital up to 180 days after randomization, in percentage.
The rate of survival with favorable outcomes ( modified Rankin score less than 3 or cerebral performance category scale 1 or 2 ) at 90 days after discharge from hospital, in percentage
From the date of randomization to 90 days after survival discharge from hospital
The rate of survival with favorable outcomes ( modified Rankin score less than 3 or cerebral performance category scale 1 or 2 ) at 180 days, in percentage
From enrollment to the end of treatment at 180 days
total duration of mechanical ventilation from randomization to discharge from hospital or up to 180 days after randomization , in days
From randomization at the emergency department to discharge from hospital or up to 180 days after randomization
- +2 more secondary outcomes
Study Arms (2)
Total ECLS in refractory OHCA
ACTIVE COMPARATOREmergency total extracorporeal life support ( ECLS ) in cardiopulmonary resuscitation of OHCA patients with refractory ventricular fibrillation or pulseless ventricular tachycardia
standard ACLS in refractory OHCA
ACTIVE COMPARATOREmergency standard advanced cardiac life support ( ACLS ) in cardiopulmonary resuscitation of OHCA patients with refractory ventricular fibrillation or pulseless ventricular tachycardia. Bailout ECMO allowed after at least 45 minutes of CPR since collapse and 119 call or at least 15 minutes since arrival at emergency department
Interventions
ECMO supported life support for cardiopulmonary resuscitation in refractory OHCA
Standard ACLS in cardioplumonary resuscitation of refractory OHCA
Eligibility Criteria
You may qualify if:
- adults aged 18-75 years old
- witnessed cardiac arrest with bystander CPR
- initial shockable rhythm as ventricular fibrillation or pulseless ventricular tachycardia ( VF/pVT )
- repeated defibrillation shocks ( more than 2 ) by external defibrillator
- estimated transportation time from 119 call to arrival at emergency service less than 30 minutes.
You may not qualify if:
- age less than 18 years or more than 75 years old
- non-shockable initial rhythm, i.e. pulseless electrical activity or asystole
- acute aortic dissection
- acute massive pulmonary embolism
- intracerebral hemorrhage
- major trauma due to blunt, penetrating or burn injury
- severe peripheral artery occlusion disease
- known pregnancy
- suicide, illicit drug overdose or intoxication
- known pre-arrest modified Rankin score ( mRS ) more than 3 or cerebral performance category scale ( CPC ) more than 2
- severe concomitant malignancy with expected life expectancy less than 1 year
- signed and effective do-not-resuscitation ( DNR ) order
- absolute contraindications to emergency coronary angiography, including known anaphylactic reaction to angiographic contrast media, acute gastrointestinal bleeding or internal bleeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shuang Ho Hospital
New Taipei, Taiwan, 23561, Taiwan
Related Publications (1)
Fu HY, Liu YH, Li SJ, Chang HC, Liu CC, Lee CM, Huang CY, Hsu CW, Ko CI, Wang YC, Chang WT, Wang TJ, Ong JR, Sun JT, Chen JS, Hsu CY, Jang SJ, Chen YL, Lin YH, Chien CY, Kung YC, Wang TL, Yu HC, Hsu CC, Chao CC, Chen CW, Hsu CY, Hsu SC, Chang TI, Yeh JS, Tsai MS, Wei LY, Chou HW, Wang CH, Chang CH, Chen CL, Tu YK, Lin JL, Chen YS. Emergency total extracorporeal life support versus standard advanced cardiac life support with rescue extracorporeal membrane oxygenation for refractory out-of-hospital cardiac arrest: protocol for the ECLS-OHCA randomized trial. Scand J Trauma Resusc Emerg Med. 2026 Feb 3. doi: 10.1186/s13049-026-01557-w. Online ahead of print.
PMID: 41630056DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Data and Safety Monitoring Committee
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2024
First Posted
November 18, 2024
Study Start
November 1, 2024
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
November 1, 2027
Last Updated
May 18, 2025
Record last verified: 2024-09